An Open Label Randomized Comparative Study to Assess the Efficacy and Tolerability of Eurartesim® Versus Chloroquine and Nonrelapse Effect With Primaquine for Uncomplicated Plasmodium Vivax Monoinfection Malaria

Trial Profile

An Open Label Randomized Comparative Study to Assess the Efficacy and Tolerability of Eurartesim® Versus Chloroquine and Nonrelapse Effect With Primaquine for Uncomplicated Plasmodium Vivax Monoinfection Malaria

Not yet recruiting
Phase of Trial: Phase IV

Latest Information Update: 16 Aug 2017

At a glance

  • Drugs Dihydroartemisinin/piperaquine (Primary) ; Chloroquine; Primaquine
  • Indications Vivax malaria
  • Focus Therapeutic Use
  • Acronyms CuraVivax
  • Most Recent Events

    • 10 Jul 2017 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top